top of page

JCRS This Month: Impact of Pupillary Dilation on IOL Calculations (2/2026)

  • 19 hours ago
  • 3 min read

Summary of the Study

Effect of Pupillary Dilation on Ocular Biometry and IOL Power Calculation Using Six New-Generation Formulas 

Purpose

This prospective study evaluated whether biometric measurements obtained after pharmacologic pupil dilation affect the accuracy of modern IOL power calculation formulas by comparing predicted refractive outcomes with actual postoperative refraction.

Study Design

  • 84 cataract eyes undergoing uncomplicated phacoemulsification.

  • Biometry measured before and after dilation using the IOLMaster 700.

  • Six formulas evaluated:

    • Barrett Universal II

    • EVO 2.0

    • Hoffer QST

    • Kane

    • LISA

    • Pearl-DGS

  • Postoperative refraction assessed at least one month after surgery.

Changes in Biometry After Dilation

The most consistent changes were:

Parameter

Change

Anterior Chamber Depth (ACD)

↑ Increased by ~0.09 mm

Lens Thickness (LT)

↓ Decreased by ~0.036 mm

Axial Length (AL)

Slight increase (~0.008 mm)

White-to-White (WTW)

Slight increase

Central Corneal Thickness (CCT)

Slight decrease

Keratometry (overall)

No significant overall change

In eyes with:

  • Long axial length (>26 mm)

  • Flat corneas (K ≤43 D)

there was a small but significant decrease in keratometry after dilation.


Effect on IOL Prediction

Compared with measurements obtained before dilation:

  • Barrett Universal II

  • EVO 2.0

  • Kane

  • LISA

  • Pearl-DGS

all demonstrated a small myopic shift in predicted postoperative refraction.

Magnitude:

Approximately −0.03 to −0.05 D

In long eyes and flatter corneas the shift was larger:

Up to approximately −0.12 to −0.15 D.


Did Dilation Reduce Accuracy?

No.

Despite the slight systematic myopic bias:

  • Mean Absolute Error (MAE) remained unchanged.

  • Median Absolute Error (MedAE) remained unchanged.

  • Percentage of eyes within ±0.5 D and ±1.0 D showed no clinically meaningful differences.

Therefore,

Measurements taken after dilation remain clinically acceptable for modern IOL calculations. 

Why Does This Happen?

Regression analysis showed the change in refractive prediction is mainly driven by:

  1. Change in Axial Length

  2. Change in Keratometry

  3. Change in ACD

  4. Change in Lens Thickness (particularly for EVO, Kane and LISA)

The deeper ACD and thinner crystalline lens after cycloplegia alter the estimated effective lens position, producing a slight myopic prediction.


Clinical Implications

The authors conclude:

  • Measuring biometry after dilation is generally safe.

  • Modern formulas are robust against these biometric changes.

  • However, eyes with long axial length and flatter corneas may experience a predictable myopic bias.

They suggest that when biometry is obtained after dilation in these extreme eyes, surgeons may consider targeting approximately +0.10 to +0.15 D more hyperopia to compensate for the expected myopic shift.


----------------------------------------------------------------------------------------------------------------------


This is an important laboratory paper because it addresses a question that has been difficult to answer in cases of refractive surprise: Can we accurately measure the power of an explanted IOL if the lens has been cut in half during explantation? 

Study

Gu S, Yan W, Khoramnia R, Auffarth GU, Łabuz G. Accuracy of measuring the diopter power of intraocular lenses after hemidissection. Journal of Cataract & Refractive Surgery. 2026. DOI: 10.1097/J.JCRS.0000000000001895.

Why this study matters

When an IOL has to be explanted because of an unexpected postoperative refractive error, surgeons often cut the lens into two pieces before removing it through a small incision.

Until now there has been uncertainty whether such a damaged lens could still be optically measured to determine whether:

  • the manufacturer produced the correct power,

  • the implanted lens was mislabeled,

  • or the refractive surprise was caused by another factor (ELP, biometry, cornea, etc.).

This paper answers that question.

Method

The investigators examined:

  • 8 monofocal IOLs

  • 2 EDOF IOLs

  • 2 trifocal IOLs

from major manufacturers.

Each lens was measured in three situations:

  1. Intact lens

  2. One half of the lens after hemidissection

  3. Both halves reassembled

using laboratory optical power measurements. They then compared the measured powers statistically.

Results

The findings were remarkably consistent.

There was no statistically significant difference between:

  • intact lens,

  • one-half measurement,

  • and reassembled halves

(p = 0.77).

Average change after cutting:

IOL type

Difference

Monofocal

0.15 ± 0.17 D

EDOF

0.10 ± 0.07 D

Trifocal

0.02 ± 0.01 D

Nearly all measurements remained within ISO tolerances.

Main conclusion

The authors concluded that:

Measuring only one half of a hemidissected IOL provides essentially the same dioptric power as measuring the intact lens.

In other words,

Cutting an IOL during explantation does not prevent accurate laboratory verification of its power. 

Why this is important clinically

For cataract surgeons investigating a refractive surprise, there are several possible causes:

  • incorrect biometry

  • wrong formula

  • ELP prediction error

  • postoperative lens position

  • transcription error

  • wrong lens implanted

  • manufacturing error

This paper shows that manufacturing error can still be investigated even after the explanted IOL has been cut during surgery, because the optical power remains measurable with excellent accuracy.

Services

Online consultation

online consultation.jpg

If you are interested to learn more on any of the content in this website, you are free to subscribe and drop me a message for an online consultation against a coffee.

Educational Purpose Only
The content provided on quickguide.org is intended solely for educational and informational purposes and is designed for eye‑care professionals, trainees, and industry professionals with relevant clinical or technical background.
 No Medical Advice
The information on this website does not constitute medical advice, diagnosis, treatment recommendations, or clinical protocols. It should not be used as a substitute for professional training, clinical judgment, manufacturer instructions for use (IFU), or institutional guidelines.
Clinical Responsibility
All clinical decisions, including but not limited to biometry measurements, IOL power calculations, formula selection, and surgical planning, remain the sole responsibility of the treating clinician. Users are expected to independently verify data and apply appropriate professional judgment.

bottom of page